Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
42,079,879
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
8,054,251
-
Shares change
-
+7,964,332
-
Total reported value, excl. options
-
$20,221,241
-
Value change
-
+$20,007,582
-
Number of buys
-
12
-
Number of sells
-
-3
-
Price
-
$2.51
Significant Holders of InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) as of Q2 2023
24 filings reported holding NSPR - InspireMD, Inc. - Common Stock, $0.0001 par value as of Q2 2023.
InspireMD, Inc. - Common Stock, $0.0001 par value (NSPR) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 8,054,251 shares
of 42,079,879 outstanding shares and own 19% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (1,860,405 shares), Nantahala Capital Management, LLC (1,860,405 shares), MARSHALL WACE, LLP (1,860,405 shares), Soleus Capital Management, L.P. (1,378,128 shares), Velan Capital Investment Management LP (904,029 shares), PURA VIDA INVESTMENTS, LLC (55,680 shares), HighTower Advisors, LLC (26,762 shares), NOTTINGHAM ADVISORS, INC. (25,000 shares), HOLLENCREST CAPITAL MANAGEMENT (20,000 shares), and RENAISSANCE TECHNOLOGIES LLC (14,200 shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.